TTT is emerging as a treatment for occult choroidal neovascularization. By penetrating deep in the choroid with infrared light at 810 mm, TTT causes heat-induced damage to the neovascular tissue while limiting injury to the neurosensory retina. Multiple pilot studies have confirmed that TTT is useful in stabilizing the visual acuity in eyes with occult CNV. Recent pilot studies have identified that TTT stabilizes visual acuity in eyes treated with classic CNV. The use of TTT to treat occult CNV is currently under investigation in the TTT4CNV trial.
|Original language||English (US)|
|Title of host publication||Age-Related Macular Degeneration|
|Number of pages||7|
|State||Published - Jan 1 2002|
ASJC Scopus subject areas